Acelrx Pharmaceuticals reported $42.81M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 42.81M 12.68M
Acura Pharmaceuticals ACUR:US 1.31M 70K
Baxter International BAX:US $ 8173M 699M
Becton, Dickinson and BDX:US $ 10152M 1845M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
Johnson & Johnson JNJ:US $ 60424M 555M
Pain Therapeutics PTIE:US $ 222.2M 22.28M
Pfizer PFE:US $ 54420M 5273M
Smiths SMIN:LN 2.86B 121M
Teva Pharmaceutical TEVA:IT 12.45B 122M
Xeris Pharmaceuticals Inc XERS:US $ 177.55M 34.95M